In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Anchor Therapeutics Inc. (formerly Ascent Therapeutics; developing pepducin drug candidates that selectively target G protein coupled receptors) has raised $10mm through its Series B financing led by returning shareholders TVM Capital, HealthCare Ventures, and the Novartis Option Fund. The company says that other investors may add money to the round.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?